Crystalline forms of ethyl 2-[[3-[[3- chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy] acetate
The present invention relates to crystalline forms of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, herein after also referred to as “compound of formula (I)”. The invention also relates to a process for the production of these crystalline forms, formulations for plant protection and herbicidal compositions which contain one of these crystalline forms.
1. A crystalline form C of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, which in an X-ray powder diffraction diagram at 25° C. and Cu-Kα radiation displays at least 3 of the following reflections, quoted as ° 2θ values: 10.6±0.2, 12.3±0.2, 15.3±0.2, 15.8±0.2, 18.3±0.2, 18.6±0.2, 19.2±0.2, 19.9±0.2, 20.6±0.2, 20.9±0.2, 21.8±0.2, 22.6±0.2, 24.5±0.2, 25.5±0.2, 26.0±0.2, 27.0±0.2 and 28.3±0.2.
2. The crystalline form C as claimed in claim 1 with a content of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate of at least 94 wt. %.
3. Ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate consisting of at least 90 wt. % of the crystalline form C.
4. The process for production of the crystalline form C as claimed in claim 1 , comprising:
i) preparation of a solution of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate in a solvent which is selected from the group consisting of aliphatic hydrocarbons, aromatic hydrocarbons, esters, ketones and alcohols;
ii) effecting a crystallization of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate.
5. A crystalline form A of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, which in an X-ray powder diffraction diagram at 25° C. and Cu-Kα radiation displays at least 3 of the following reflections, quoted as ° 2θ values: 4.7±0.2, 7.5±0.2, 9.5±0.2, 12.2±0.2, 12.9±0.2, 13.7±0.2, 14.3±0.2, 14.5±0.2, 19.3±0.2, 20.1±0.2 and 24.7±0.2.
6. A crystalline form B of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, which in an X-ray powder diffraction diagram at 25° C. and Cu-Kα radiation displays at least 3 of the following reflections, quoted as ° 2θ values: 7.1±0.2, 9.4±0.2, 9.8±0.2, 11.6±0.2, 13.6±0.2, 13.9±0.2, 15.3±0.2, 18.3±0.2, 19.0±0.2, 20.0±0.2, 20.8±0.2, 21.6±0.2, 22.3±0.2, 24.5±0.2 and 27.2±0.2.
7. A crystalline form D of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, which in an X-ray powder diffraction diagram at 25° C. and Cu-Kα radiation displays at least 3 of the following reflections, quoted as ° 2θ values: 5.2±0.2, 6.9±0.2, 10.4±0.2, 14.7±0.2, 18.9±0.2, 20.1±0.2, 21.6±0.2, 22.1±0.2, 23.0±0.2 and 24.7±0.2.
8. A plant protection agent containing ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, which consists of one or more of crystalline forms A, B, C, and D in at least 90 wt %, and one or more additives customary for the formulation of plant protection agents.
9. The plant protection agent as claimed in claim 8 in the form of an aqueous suspension concentrate.
10. The plant protection agent as claimed in claim 8 in the form of a non-aqueous suspension concentrate.
11. The plant protection agent as claimed in claim 8 in the form of a powder or granules dispersible in water.
12. A method for combatting undesired plant growth comprising applying to plants, the habitat thereof, or seeds an effective amount of an agent containing ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]pxy] acetate, wherein one or more crystalline forms A, B, C, and D is present in at least 90 wt %.